XRTX

XORTX Therapeutics
XRTX

3 hedge funds and large institutions have $6.25K invested in XORTX Therapeutics in 2026 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, reducing their positions, and 5 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $
Holders
3
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$7K
2
+$21

Top Sellers

1
-$109K
2
-$7.08K
3
-$4.74K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$2K
5
UBS Group
UBS Group
Switzerland
-$787
Name Holding Trade Value Shares
Change 		Change in
Stake
KWM
1
Kingsview Wealth Management
Oregon
$6.13K
CA
2
Clearstead Advisors
Ohio
$92
TWC
3
TD Waterhouse Canada
Ontario, Canada
$19
DS
4
DRW Securities
Illinois
–
BBA
5
Baader Bank Aktiengesellschaft
Germany
–
TSS
6
Two Sigma Securities
New York
–
Royal Bank of Canada
7
Royal Bank of Canada
Ontario, Canada
–
UBS Group
8
UBS Group
Switzerland
–